Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred


IMPACT FACTOR 2018: 3.014
5-year IMPACT FACTOR: 3.162

CiteScore 2018: 3.09

SCImago Journal Rank (SJR) 2018: 1.482
Source Normalized Impact per Paper (SNIP) 2018: 0.820

Online
ISSN
1437-4315
See all formats and pricing
More options …
Volume 392, Issue 3

Issues

Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site

Kerstin Kühn-Wache
  • Probiodrug AG, Weinbergweg 22, Biocenter, D-06120 Halle, Germany
  • These authors contributed equally to this work.
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Joachim W. Bär
  • Probiodrug AG, Weinbergweg 22, Biocenter, D-06120 Halle, Germany
  • These authors contributed equally to this work.
  • Present address: Boehringer Ingelheim Pharma GmbH&Co. KG, Birkendorfer Straße 65, D-88397 Biberach an der Riss, Germany.
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Torsten Hoffmann / Raik Wolf / Jens-Ulrich Rahfeld / Hans-Ulrich Demuth
Published Online: 2011-06-18 | DOI: https://doi.org/10.1515/bc.2011.028

Abstract

Dipeptidyl peptidase 4/CD26 (DP4) is a multifunctional serine protease liberating dipeptide from the N-terminus of (oligo)peptides which can modulate the activity of these peptides. The enzyme is involved in physiological processes such as blood glucose homeostasis and immune response. DP4 substrate specificity is characterized in detail using synthetic dipeptide derivatives. The specificity constant k cat/K m strongly depends on the amino acid in P1-position for proline, alanine, glycine and serine with 5.0×105 m -1s-1, 1.8×104 m -1s-1, 3.6×102 m -1s-1, 1.1×102 m -1s-1, respectively. By contrast, kinetic investigation of larger peptide substrates yields a different pattern. The specific activity of DP4 for neuropeptide Y (NPY) cleavage comprising a proline in P1-position is the same range as the k cat/K m values of NPY derivatives containing alanine or serine in P1-position with 4×105 m -1s-1, 9.5×105 m -1s-1 and 2.1×105 m -1s-1, respectively. The proposed existence of an additional binding region outside the catalytic center is supported by measurements of peptide substrates with extended chain length. This ‘secondary’ binding site interaction depends on the amino acid sequence in P4′–P8′-position. Interactions with this binding site could be specifically blocked for substrates of the GRF/glucagon peptide family. By contrast, substrates not belonging to this peptide family and dipeptide derivative substrates that only bind to the catalytic center of DP4 were not inhibited. This more selective inhibition approach allows, for the first time, to distinguish between substrate families by substrate-discriminating inhibitors.

Keywords: dipeptidyl peptidase 4; neuropeptide Y; secondary binding site; substrates; substrate-specific inhibition

About the article

Corresponding author


Received: 2010-09-20

Accepted: 2010-12-21

Published Online: 2011-06-18

Published in Print: 2011-03-01


Citation Information: Biological Chemistry, Volume 392, Issue 3, Pages 223–231, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/bc.2011.028.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Orla Power, A. B. Nongonierma, P. Jakeman, and R. J. FitzGerald
Proceedings of the Nutrition Society, 2014, Volume 73, Number 1, Page 34
[2]
Xing Chen, Elizabeth G. Mietlicki-Baase, Taylor M. Barrett, Lauren E. McGrath, Kieran Koch-Laskowski, John J. Ferrie, Matthew R. Hayes, and E. James Petersson
Journal of the American Chemical Society, 2017
[3]
Alice B Nongonierma, Solène Le Maux, Claire Esteveny, and Richard J FitzGerald
Journal of the Science of Food and Agriculture, 2017, Volume 97, Number 4, Page 1093
[4]
Isabelle Lacroix and Eunice Li-Chan
International Journal of Molecular Sciences, 2014, Volume 15, Number 11, Page 20846
[6]
Alice B. Nongonierma, Catherine Mooney, Denis C. Shields, and Richard J. FitzGerald
Peptides, 2014, Volume 57, Page 43
[7]
Vu Thi Tuyet Lan, Keisuke Ito, Sohei Ito, and Yasuaki Kawarasaki
Peptides, 2014, Volume 54, Page 166
[9]
Alice B. Nongonierma and Richard J. FitzGerald
Food & Function, 2013, Volume 4, Number 12, Page 1843
[10]
Kathryn R. Heard, Wengen Wu, Youhua Li, Peng Zhao, Iwona Woznica, Jack H. Lai, Martin Beinborn, David G. Sanford, Matthew T. Dimare, Amrita K. Chiluwal, Diane E. Peters, Danielle Whicher, James L. Sudmeier, and William W. Bachovchin
Journal of Medicinal Chemistry, 2013, Volume 56, Number 21, Page 8339
[11]
Alice B. Nongonierma and Richard J. FitzGerald
Food Chemistry, 2014, Volume 145, Page 845
[13]
Larry K. Golightly, Caitlin C. Drayna, and Michael T. McDermott
Clinical Pharmacokinetics, 2012, Volume 51, Number 8, Page 501
[14]
Alice B. Nongonierma, Catherine Mooney, Denis C. Shields, and Richard J. FitzGerald
Food Chemistry, 2013, Volume 141, Number 1, Page 644
[15]
Aya Hikida, Keisuke Ito, Takayasu Motoyama, Ryuji Kato, and Yasuaki Kawarasaki
Biochemical and Biophysical Research Communications, 2013, Volume 430, Number 4, Page 1217
[16]
Isabelle M.E. Lacroix and Eunice C.Y. Li-Chan
Journal of Functional Foods, 2012, Volume 4, Number 2, Page 403
[17]
Laura Mendieta, Teresa Tarrago, and Ernest Giralt
Expert Opinion on Therapeutic Patents, 2011, Volume 21, Number 11, Page 1693
[18]
Torsten Hoffmann and Hans-Ulrich Demuth
Biological Chemistry, 2011, Volume 392, Number 3

Comments (0)

Please log in or register to comment.
Log in